Marijuana And Hemp Leaders Have Found Agreement On Many Significant Policy Issues (Op-Ed)
“With marijuana and hemp leaders working together toward a shared vision of more effective federal policy, the path ahead is brighter for the entire cannabinoid marketplace.” By Adam Rosenberg, National Cannabis Industry Association and Eric Berlin, Dentons Last fall, we wrote that marijuana and hemp businesses were working together as a group informally called the […]
New Cannabis Group Will Help Ground Policy In Science And Patient Experience As Trump’s Rescheduling Move Advances (Op-Ed)
“Federal policy must reflect evidence and science, not dispelled myths and tired stereotypes.” By Sasha Kalcheff-Korn, National Compassionate Care Council Recent federal action initiating a review of cannabis scheduling and signaling interest in expanding cannabinoid research reflects a growing willingness to examine how federal policy aligns with emerging evidence and real-world patient experience—but it also […]
Trump’s Cannabis Rescheduling Move Alone Won’t Stabilize The Industry Without Insurance Reimbursement Reform (Op-Ed)
“A stable cannabis industry requires more than tax normalization. It requires integration into healthcare infrastructure that governs how therapeutic products are accessed, financed and sustained.” By Gennaro Luce and Matthew Myro Rothman, CannaLnx Momentum around federal cannabis reform has shifted. Following President Donald Trump’s executive order directing the rescheduling of cannabis, investors have interpreted the […]
Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)
“Other states as well should learn from Michigan’s experience, rather than repeat the same economic misstep the next time they face a budget shortfall.” By Hirsh Jain, Verdant Strategies In an effort to raise short-term revenue, Michigan recently adopted a cannabis tax structure that is already proving economically counterproductive and strategically shortsighted. For years, Michigan […]